<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Il'ina IV</submitter><funding>Russian Foundation for Basic Research</funding><funding>Russian Science Foundation</funding><pagination>E3496</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7436013</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(15)</volume><pubmed_abstract>Two novel structural types of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors with hexahydroisobenzofuran &lt;b>11&lt;/b> and 3-oxabicyclo [3.3.1]nonane &lt;b>12&lt;/b> scaffolds were discovered. These monoterpene-derived compounds were synthesized through preliminary isomerization of (+)-3-carene to (+)-2-carene followed by reaction with heteroaromatic aldehydes. All the compounds inhibit the TDP1 enzyme at micro- and submicromolar levels, with the most potent compound having an IC&lt;sub>50&lt;/sub> value of 0.65 μM. TDP1 is an important DNA repair enzyme and a promising target for the development of new chemosensitizing agents. A panel of isogenic clones of the HEK293FT cell line knockout for the &lt;i>TDP1&lt;/i> gene was created using the CRISPR-Cas9 system. Cytotoxic effects of topotecan (Tpc) and non-cyt</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1.</pubmed_title><pmcid>PMC7436013</pmcid><funding_grant_id>19-13-00040</funding_grant_id><funding_grant_id>19-415-540002</funding_grant_id><pubmed_authors>Reynisson J</pubmed_authors><pubmed_authors>Lavrik OI</pubmed_authors><pubmed_authors>Chepanova AA</pubmed_authors><pubmed_authors>Chand R</pubmed_authors><pubmed_authors>Il'ina IV</pubmed_authors><pubmed_authors>Zakharenko AL</pubmed_authors><pubmed_authors>Li-Zhulanov NS</pubmed_authors><pubmed_authors>Dyrkheeva NS</pubmed_authors><pubmed_authors>Ilina ES</pubmed_authors><pubmed_authors>Medvedev SP</pubmed_authors><pubmed_authors>Salakhutdinov NF</pubmed_authors><pubmed_authors>Ayine-Tora DM</pubmed_authors><pubmed_authors>Sidorenko AY</pubmed_authors><pubmed_authors>Volcho KP</pubmed_authors><pubmed_authors>Malakhova AA</pubmed_authors><pubmed_authors>Zakharova OD</pubmed_authors><pubmed_authors>Zakian SM</pubmed_authors><pubmed_authors>Korchagina DV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1.</name><description>Two novel structural types of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors with hexahydroisobenzofuran &lt;b>11&lt;/b> and 3-oxabicyclo [3.3.1]nonane &lt;b>12&lt;/b> scaffolds were discovered. These monoterpene-derived compounds were synthesized through preliminary isomerization of (+)-3-carene to (+)-2-carene followed by reaction with heteroaromatic aldehydes. All the compounds inhibit the TDP1 enzyme at micro- and submicromolar levels, with the most potent compound having an IC&lt;sub>50&lt;/sub> value of 0.65 μM. TDP1 is an important DNA repair enzyme and a promising target for the development of new chemosensitizing agents. A panel of isogenic clones of the HEK293FT cell line knockout for the &lt;i>TDP1&lt;/i> gene was created using the CRISPR-Cas9 system. Cytotoxic effects of topotecan (Tpc) and non-cyt</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2026-04-30T07:42:36.517Z</modification><creation>2026-04-07T15:54:46.729Z</creation></dates><accession>S-EPMC7436013</accession><cross_references><pubmed>32751997</pubmed><doi>10.3390/molecules25153496</doi></cross_references></HashMap>